Helen Boulton
Manchester Royal Infirmary
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Helen Boulton.
American Journal of Nephrology | 1993
John Harty; Helen Boulton; Nita Heelis; Linda Uttley; Michael Venning; Ram Gokal
Nutrition has been shown to predict clinical outcome in continuous ambulatory peritoneal dialysis (CAPD) patients. However, despite the positive relationship between KT/V (urea) and the normalised protein catabolic rate, the ability of urea kinetic modelling to predict clinical outcome or nutrition remains inconclusive. We have evaluated the relationship between nutrition and achieved dialysis in a cross-sectional study of 147 stable CAPD patients on dialysis for a mean period of 22 months. Protein-energy malnutrition was present in 22-32% of the study population. 39 and 41% of the population failed to achieve suggested adequacy targets of 50 liters/week for total creatinine clearance and a weekly KT/V (urea) of 1.7, respectively. Severely malnourished patients had significantly greater normalised clearance and adequacy values than well-nourished patients. Intrinsic actual peritoneal clearance bore no relation to patient size. The subsequent normalisation of this value by a component of patient mass results in a mathematical bias against well-nourished or obese patients. This may explain the failure of such adequacy values to reflect outcome and argues against accepting such values as measures of dialysis well-being.
Nephron | 1996
Alastair J. Hutchison; A. J. O. Were; Helen Boulton; E. B. Mawer; I. Laing; Ram Gokal
Phosphate binders are necessary to control hyperphosphataemia in the majority of dialysis patients. Whilst aluminium salts are efficient phosphate binders, their use is associated with toxic side effects. Calcium salts are a widely used alternative, but hypercalcaemia is a common side effect, limiting their use and raising concern about metastatic calcification. Reduction of the dialysis fluid calcium concentration has been shown to reduce hypercalcaemia in haemodialysis patients, with an associated decrease in serum PTH. We analysed the effect of reduced calcium/magnesium (1.25/0.25 mmol/l), 40 mmol/l lactate, PD fluid (PD4) on 11 CAPD patients with uncontrollable hypercalcaemia (> 2.65 mmol/l) and hyperphosphataemia (> 1.80 mmol/l). Only 1 patient remained hypercalcaemic, while phosphate fell in 6 patients (2.23 +/- 0.16 on no binder, to 1.68 +/- 0.08 mmol/l at 6 months (p < 0.05), but was unchanged in 5 (2.10 +/- 0.15 to 2.48 +/- 0.14 mmol/l [p = NS]). Overall mean calcium x phosphate product changed little. However, in a subgroup it fell significantly (p < 0.05). Geometric mean iPTH rose, but not significantly. The subgroup of patients whose calcium x phosphate product fell, exhibited a much smaller rise in iPTH than the others (57.3-73.2 vs. 52.8-167.1 pg/ml). 1.25-Dihydroxyvitamin D3 was subnormal in all patients. Mean serum magnesium fell from 1.24 +/- 0.06 to 0.89 +/- 0.04 mmol/l (p < 0.001), whilst mean serum bicarbonate rose significantly (25.2 +/- 0.4 to 28.9 +/- 1.2 mmol/l; p < 0.01). Withdrawal of aluminium-containing phosphate binders resulted in mean serum aluminium falling significantly from 31.1 +/- 5.7 at start of PD4 to 15.4 +/- 2.7 mu g/l at 6 months (p < 0.05). In summary, in around 50% of CAPD patients with persistent hypercalcaemia and hyperphosphataemia, reduction in PD fluid calcium can produce significant improvement in phosphate, reduction of calcium x phosphate product, and enable avoidance of aluminium-containing phosphate binders. Patients whose calcium and phosphate control remains poor, still benefit from the reduction, or cessation, of oral aluminium intake.
Nephron | 1993
Alastair J. Hutchison; Helen Boulton; Ram Gokal
A 25-year-old male patient underwent abdominal radiotherapy following the discovery of lymphadenopathy associated with a testicular teratoma. Prior to treatment, his peritoneal mass transfer area coefficients were within normal limits. One and 2 months after treatment, peritoneal permeability had increased to the extent that continuous ambulatory peritoneal dialysis was rendered impractical.
Kidney International | 1993
Alastair J. Hutchison; Rick W. Whitehouse; Helen Boulton; Judy E. Adams; E. Barbara Mawer; Tony Freemont; Ram Gokal
Kidney International | 1994
John Harty; Helen Boulton; Janet Curwell; Nita Heelis; Linda Uttley; Michael Venning; Ram Gokal
Nephrology Dialysis Transplantation | 1992
Alastair J. Hutchison; A. J. Freemont; Helen Boulton; Ram Gokal
Nephrology Dialysis Transplantation | 1995
John Harty; D. J. A. Goldsmith; Helen Boulton; N. Heelis; Linda Uttley; J. Morris; Michael Venning; Ram Gokal
Archive | 1994
John Harty; Helen Boulton; Janet Curwell; Nita Heelis; Linda Uttley; Michael Venning; Ram Gokal
American Journal of Nephrology | 1993
Ja-Liang Lin; Kuan-Hung Yeh; Hsun-Chih Tseng; Wei-Yu Chen; Hsien-Hung Lai; Yu-Ching Lin; Adeera Levin; Ravindra L. Mehta; Marc B. Goldstein; John Harty; Helen Boulton; Nita Heelis; Linda Uttley; Michael Venning; Ram Gokal; J. De Kimpe; R. Cornelis; L. Mees; S. Van Lierde; R. Vanholder; Jeremy Hughes; Roswell J. Martin; Elaine J. Clutterbuck; Mohamed A. Ghoneim; Mohamed Sobh; Ahmed A. Shokeir; Mohamed A. Bakr; Assem K. El-Sherif; Mohamed Ashraf Fouda; Miroslav Mydlík
American Journal of Nephrology | 1993
Ja-Liang Lin; Kuan-Hung Yeh; Hsun-Chih Tseng; Wei-Yu Chen; Hsien-Hung Lai; Yu-Ching Lin; Adeera Levin; Ravindra L. Mehta; Marc B. Goldstein; John Harty; Helen Boulton; Nita Heelis; Linda Uttley; Michael Venning; Ram Gokal; J. De Kimpe; R. Cornelis; L. Mees; S. Van Lierde; R. Vanholder; Jeremy Hughes; Roswell J. Martin; Elaine J. Clutterbuck; Mohamed A. Ghoneim; Mohamed Sobh; Ahmed A. Shokeir; Mohamed A. Bakr; Assem K. El-Sherif; Mohamed Ashraf Fouda; Miroslav Mydlík